Human Sperm Cryopreservation as an Alternative to the Decline of Sperm Quality With Aging
8 septembre 2026 mis à jour par: IVI Murcia
This observational study will evaluate whether sperm cryopreservation can help preserve sperm quality and molecular characteristics that may be affected by increasing paternal age.
Men aged 18 years and older will provide a semen sample and a blood sample for laboratory analysis.
Each semen sample will be divided into fresh, slow-frozen, and vitrified aliquots.
The study will compare sperm quality (as assessed by computer-assisted sperm analysis), DNA methylation profiles, DNA fragmentation, sperm telomere length before and after cryopreservation.
The effects of age on these parameters will also be assessed.
The impact of age on seminal plasma extracellular vesicle composition and blood cell telomere length will also be analysed.
The goal is to determine whether sperm cryopreservation may represent a strategy for preserving sperm characteristics associated with younger paternal age.
Aperçu de l'étude
Statut
Recrutement
Description détaillée
The aging process is associated with declining fertility and increased risks of adverse reproductive and offspring health outcomes. Although the effects of maternal age have been extensively studied, the impact of paternal aging on sperm quality, reproductive outcomes, and molecular characteristics of sperm remains incompletely understood.
The primary objective of this study is to evaluate whether sperm cryopreservation may serve as an alternative to the use of sperm collected at older ages in assisted reproduction treatments. The primary endpoint is the difference in sperm DNA methylation patterns between fresh ejaculated samples and samples subjected to cryopreservation. Cryopreservation will be considered a potentially valid strategy if DNA methylation patterns remain substantially preserved following the cryopreservation process.
At least 45 male participants will be recruited and grouped according to age. Participants will provide one semen sample and a peripheral blood sample. Following routine semen analysis, each semen sample will be divided into three aliquots: fresh, slow-frozen, and vitrified. Cryopreserved aliquots will be stored in liquid nitrogen and subsequently thawed or warmed for analysis.
Standard semen parameters, including volume, concentration, motility, sperm kinetics, and morphology, will be evaluated. Additional analyses will include sperm DNA methylation, DNA fragmentation, telomere length, and characterization of extracellular vesicles and their composition. Identical assessments will be performed on fresh and cryopreserved samples to compare the effects of slow freezing and vitrification.
Secondary objectives include evaluating age-related differences in semen quality and molecular biomarkers, identifying markers associated with biological gamete age, characterizing age-related differences in seminal extracellular vesicles, and exploring associations between sperm molecular characteristics and lifestyle. Participants will also complete validated questionnaires regarding lifestyle and dietary habits.
Type d'étude
Observationnel
Inscription (Estimé)
45
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Lieux d'étude
-
-
Murcia
-
Murcia, Murcia, Espagne, 30007
- Recrutement
- IVI Murcia
-
Contact:
- Juan Carlos Martínez
- Numéro de téléphone: +34 651 79 10 00
- E-mail: JuanCarlos.Martinez@ivirma.com
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Oui
Méthode d'échantillonnage
Échantillon non probabiliste
Population étudiée
Adult men aged 18-65 years attending IVI Murcia for semen analysis, fertility assessment, semen donation, or assisted reproduction treatment who meet the study eligibility criteria and provide informed consent.
Participants will provide semen and blood samples for laboratory assessment of sperm quality and molecular characteristics before and after cryopreservation.
La description
Inclusion Criteria:
- Male participants aged 18 to 65 years
- Attending IVI Murcia for semen analysis and/or assisted reproduction treatment
- Able and willing to provide written informed consent
- Willing to provide a semen sample and a blood sample for research purposes
Exclusion Criteria:
- Previous diagnosis of azoospermia or severe oligozoospermia (sperm concentration <1 million sperm/mL)
- Known chromosomal abnormality (abnormal karyotype)
- Known Y chromosome microdeletion
- Febrile illness within the previous 3 months
- Presence of varicocele
- Current use of vitamin or antioxidant supplements intended to improve semen quality
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
|---|
|
Men aged 18-39 years
Male participants aged 18-39 years who provide semen and blood samples for laboratory assessment of sperm quality and molecular characteristics.
Semen samples are divided into fresh, slow-frozen, and vitrified aliquots for comparative analysis.
|
|
Men aged 40-49 years
Male participants aged 40-49 years who provide semen and blood samples for laboratory assessment of sperm quality and molecular characteristics.
Semen samples are divided into fresh, slow-frozen, and vitrified aliquots for comparative analysis.
|
|
Men aged ≥50 years
Male participants aged 50 years and older who provide semen and blood samples for laboratory assessment of sperm quality and molecular characteristics.
Semen samples are divided into fresh, slow-frozen, and vitrified aliquots for comparative analysis.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Sperm DNA methylation profile
Délai: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
|
DNA methylation levels of a predefined nine-gene panel measured by pyrosequencing with duplicate measurements and compared between fresh, slow-frozen, and vitrified sperm samples.
|
Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Sperm concentration
Délai: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
|
Sperm concentration (million sperm/mL) measured using computer-assisted sperm analysis (CASA).
|
Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
|
|
Total sperm motility
Délai: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
|
Percentage of motile sperm measured using CASA.
|
Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
|
|
Progressive sperm motility
Délai: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
|
Percentage of progressively motile sperm measured using computer-assisted sperm analysis (CASA).
|
Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
|
|
Normal sperm morphology
Délai: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
|
Percentage of sperm with normal morphology assessed by microscopic evaluation of stained slides according to World Health Organization (WHO) criteria.
|
Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
|
|
Sperm DNA fragmentation
Délai: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
|
DNA fragmentation measured in fresh, slow-frozen, and vitrified sperm samples.
|
Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
|
|
Sperm telomere length
Délai: Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
|
Sperm telomere length measured in fresh, slow-frozen, and vitrified sperm samples.
|
Baseline (study semen collection visit) and after thawing of cryopreserved semen samples, through study completion (up to 9 months).
|
|
Seminal plasma extracellular vesicle composition
Délai: Baseline (study semen collection visit).
|
Characterization of seminal plasma extracellular vesicle composition in fresh semen samples.
|
Baseline (study semen collection visit).
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Blood leukocyte telomere length
Délai: Baseline (study blood collection visit).
|
Blood cell telomere length measured to investigate its relationship with participant age and sperm molecular characteristics.
|
Baseline (study blood collection visit).
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Collaborateurs
Publications et liens utiles
La personne responsable de la saisie des informations sur l'étude fournit volontairement ces publications. Il peut s'agir de tout ce qui concerne l'étude.
Publications générales
- Blackburn EH, Gall JG. A tandemly repeated sequence at the termini of the extrachromosomal ribosomal RNA genes in Tetrahymena. J Mol Biol. 1978 Mar 25;120(1):33-53. doi: 10.1016/0022-2836(78)90294-2. No abstract available.
- Hezavehei M, Sharafi M, Kouchesfahani HM, Henkel R, Agarwal A, Esmaeili V, Shahverdi A. Sperm cryopreservation: A review on current molecular cryobiology and advanced approaches. Reprod Biomed Online. 2018 Sep;37(3):327-339. doi: 10.1016/j.rbmo.2018.05.012. Epub 2018 Aug 22.
- Wang W, Todorov P, Pei C, Wang M, Isachenko E, Rahimi G, Mallmann P, Isachenko V. Epigenetic Alterations in Cryopreserved Human Spermatozoa: Suspected Potential Functional Defects. Cells. 2022 Jul 4;11(13):2110. doi: 10.3390/cells11132110.
- Wang D, Jueraitetibaike K, Tang T, Wang Y, Jing J, Xue T, Ma J, Cao S, Lin Y, Li X, Ma R, Chen X, Yao B. Seminal Plasma and Seminal Plasma Exosomes of Aged Male Mice Affect Early Embryo Implantation via Immunomodulation. Front Immunol. 2021 Oct 12;12:723409. doi: 10.3389/fimmu.2021.723409. eCollection 2021.
- Tao Y, Sanger E, Saewu A, Leveille MC. Human sperm vitrification: the state of the art. Reprod Biol Endocrinol. 2020 Mar 7;18(1):17. doi: 10.1186/s12958-020-00580-5.
- Sysoeva AP, Makarova NP, Silachev DN, Lobanova NN, Shevtsova YA, Bragina EE, Kalinina EA, Sukhikh GT. Influence of Extracellular Vesicles of the Follicular Fluid on Morphofunctional Characteristics of Human Sperm. Bull Exp Biol Med. 2021 Dec;172(2):254-262. doi: 10.1007/s10517-021-05372-4. Epub 2021 Dec 2.
- Khosravizadeh Z, Khodamoradi K, Rashidi Z, Jahromi M, Shiri E, Salehi E, Talebi A. Sperm cryopreservation and DNA methylation: possible implications for ART success and the health of offspring. J Assist Reprod Genet. 2022 Aug;39(8):1815-1824. doi: 10.1007/s10815-022-02545-6. Epub 2022 Jun 17.
- Sciamanna I, Serafino A, Shapiro JA, Spadafora C. The active role of spermatozoa in transgenerational inheritance. Proc Biol Sci. 2019 Aug 28;286(1909):20191263. doi: 10.1098/rspb.2019.1263. Epub 2019 Aug 28.
- Reshi QUA, Godakumara K, Ord J, Dissanayake K, Hasan MM, Andronowska A, Heath P, Fazeli A. Spermatozoa, acts as an external cue and alters the cargo and production of the extracellular vesicles derived from oviductal epithelial cells in vitro. J Cell Commun Signal. 2023 Sep;17(3):737-755. doi: 10.1007/s12079-022-00715-w. Epub 2022 Dec 5.
- Practice Committee of the American Society for Reproductive Medicine. The clinical utility of sperm DNA integrity testing: a guideline. Fertil Steril. 2013 Mar 1;99(3):673-7. doi: 10.1016/j.fertnstert.2012.12.049. Epub 2013 Feb 1.
- Njajou OT, Cawthon RM, Damcott CM, Wu SH, Ott S, Garant MJ, Blackburn EH, Mitchell BD, Shuldiner AR, Hsueh WC. Telomere length is paternally inherited and is associated with parental lifespan. Proc Natl Acad Sci U S A. 2007 Jul 17;104(29):12135-9. doi: 10.1073/pnas.0702703104. Epub 2007 Jul 10.
- Machtinger R, Laurent LC, Baccarelli AA. Extracellular vesicles: roles in gamete maturation, fertilization and embryo implantation. Hum Reprod Update. 2016 Mar-Apr;22(2):182-93. doi: 10.1093/humupd/dmv055. Epub 2015 Dec 9.
- Lismer A, Kimmins S. Emerging evidence that the mammalian sperm epigenome serves as a template for embryo development. Nat Commun. 2023 Apr 14;14(1):2142. doi: 10.1038/s41467-023-37820-2.
- Laurentino S, Cremers JF, Horsthemke B, Tuttelmann F, Czeloth K, Zitzmann M, Pohl E, Rahmann S, Schroder C, Berres S, Redmann K, Krallmann C, Schlatt S, Kliesch S, Gromoll J. A germ cell-specific ageing pattern in otherwise healthy men. Aging Cell. 2020 Oct;19(10):e13242. doi: 10.1111/acel.13242. Epub 2020 Sep 20.
- Kumar P, Wang M, Isachenko E, Rahimi G, Mallmann P, Wang W, von Brandenstein M, Isachenko V. Unraveling Subcellular and Ultrastructural Changes During Vitrification of Human Spermatozoa: Effect of a Mitochondria-Targeted Antioxidant and a Permeable Cryoprotectant. Front Cell Dev Biol. 2021 Jul 2;9:672862. doi: 10.3389/fcell.2021.672862. eCollection 2021.
- Klaver R, Bleiziffer A, Redmann K, Mallidis C, Kliesch S, Gromoll J. Routine cryopreservation of spermatozoa is safe--evidence from the DNA methylation pattern of nine spermatozoa genes. J Assist Reprod Genet. 2012 Sep;29(9):943-50. doi: 10.1007/s10815-012-9813-z. Epub 2012 Jun 13.
- Khosronezhad N, Hassanzadeh V, Hezavehei M, Shahverdi AH, Shahhoseini M. Comparative Epigenetic Analysis of Imprinting Genes Involved in Fertility, in Cryopreserved Human Sperms with Rapid Freezing versus Vitrification Methods. Cell J. 2023 Apr 1;25(4):238-246. doi: 10.22074/cellj.2023.1974291.1171.
- Jenkins TG, Aston KI, Cairns B, Smith A, Carrell DT. Paternal germ line aging: DNA methylation age prediction from human sperm. BMC Genomics. 2018 Oct 22;19(1):763. doi: 10.1186/s12864-018-5153-4.
- Jenkins TG, Aston KI, Carrell DT. Sperm epigenetics and aging. Transl Androl Urol. 2018 Jul;7(Suppl 3):S328-S335. doi: 10.21037/tau.2018.06.10.
- Voros C, Chatzinikolaou F, Papadimas G, Polykalas S, Mavrogianni D, Koulakmanidis AM, Athanasiou D, Kanaka V, Kanaka M, Bananis K, Athanasiou A, Athanasiou A, Papapanagiotou I, Vaitsis D, Tsimpoukelis C, Daskalaki MA, Theodora M, Thomakos N, Antsaklis P, Loutradis D, Daskalakis G. Sperm-Derived Extracellular Vesicles (Sperm-EVs), Emerging Biomarkers and Functional Modulators in Male Infertility and Assisted Reproduction. Genes (Basel). 2025 Nov 22;16(12):1400. doi: 10.3390/genes16121400.
- Fernandez de la Puente M, Salas-Huetos A, Valle-Hita C, Babio N, Murphy MM, Canudas S, Salas-Salvado J. Is telomere length a biomarker of sperm quality? A systematic review and meta-analysis of observational studies. Andrology. 2024 Feb;12(2):277-288. doi: 10.1111/andr.13482. Epub 2023 Jun 25.
- Ferlin A, Rampazzo E, Rocca MS, Keppel S, Frigo AC, De Rossi A, Foresta C. In young men sperm telomere length is related to sperm number and parental age. Hum Reprod. 2013 Dec;28(12):3370-6. doi: 10.1093/humrep/det392. Epub 2013 Oct 27.
- Estudillo E, Jimenez A, Bustamante-Nieves PE, Palacios-Reyes C, Velasco I, Lopez-Ornelas A. Cryopreservation of Gametes and Embryos and Their Molecular Changes. Int J Mol Sci. 2021 Oct 8;22(19):10864. doi: 10.3390/ijms221910864.
- Eisenberg DTA, Lee NR, Rej PH, Hayes MG, Kuzawa CW. Older paternal ages and grandpaternal ages at conception predict longer telomeres in human descendants. Proc Biol Sci. 2019 May 29;286(1903):20190800. doi: 10.1098/rspb.2019.0800. Epub 2019 May 29.
- De Meyer T, Rietzschel ER, De Buyzere ML, De Bacquer D, Van Criekinge W, De Backer GG, Gillebert TC, Van Oostveldt P, Bekaert S; Asklepios investigators. Paternal age at birth is an important determinant of offspring telomere length. Hum Mol Genet. 2007 Dec 15;16(24):3097-102. doi: 10.1093/hmg/ddm271. Epub 2007 Sep 19.
- Chen H, Alves MBR, Belleannee C. Contribution of epididymal epithelial cell functions to sperm epigenetic changes and the health of progeny. Hum Reprod Update. 2021 Dec 21;28(1):51-66. doi: 10.1093/humupd/dmab029.
- Caroppo E, Skinner MK. Could the sperm epigenome become a diagnostic tool for evaluation of the infertile man? Hum Reprod. 2024 Mar 1;39(3):478-485. doi: 10.1093/humrep/dead266.
- Aston KI, Hunt SC, Susser E, Kimura M, Factor-Litvak P, Carrell D, Aviv A. Divergence of sperm and leukocyte age-dependent telomere dynamics: implications for male-driven evolution of telomere length in humans. Mol Hum Reprod. 2012 Nov;18(11):517-22. doi: 10.1093/molehr/gas028. Epub 2012 Jul 9.
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Réel)
10 juin 2026
Achèvement primaire (Estimé)
31 mars 2027
Achèvement de l'étude (Estimé)
30 septembre 2027
Dates d'inscription aux études
Première soumission
29 juin 2026
Première soumission répondant aux critères de contrôle qualité
8 septembre 2026
Première publication (Réel)
10 septembre 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
10 septembre 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
8 septembre 2026
Dernière vérification
1 septembre 2026
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 2303-MUR-046-JM
- 101120126 (Autre subvention/numéro de financement: European Union Horizon Europe Programme - Marie Skłodowska-Curie Actions Doctoral Network AFRODITA)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
INDÉCIS
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .